Our study shows that QD-labelled sdAbs targeting the tumour-associated antigen HER2 or CEA are highly efficient tools for the detection of not only primary tumours, but also disseminated tumour cells and micrometastases in different organs with high brightness and sensitivity. Here, CEACAM5 is linked to neoplasm.